1h Free Analyst Time
The neurovascular devices market is forecasted to grow by USD 777.4 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the neurovascular devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of favorable reimbursement coverage, outsourcing neurovascular devices research to CROs, and increasing incidence of aneurysms.
The neurovascular devices market is segmented as below:
By Product
- Embolization devices
- Revascularization devices
- Embolic protection devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the neurovascular devices market covers the following areas:
- Neurovascular devices market sizing
- Neurovascular devices market forecast
- Neurovascular devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global neurovascular devices market: Acandis GmbH, Asahi Intecc Co. Ltd., BALT Group, Cerus Endovascular Inc., Evasc Medical Systems Corp., Imperative Care Inc., Integer Holdings Corp., Integra Lifesciences Corp., Johnson and Johnson Services Inc., Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., Penumbra Inc., Perflow Medical Ltd., phenox GmbH, Rapid Medical Ltd., SENSOME, Stryker Corp., and Terumo Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is market expansion in emerging economies."
According to the report, one of the major drivers for this market is the availability of favorable reimbursement coverage.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- BALT Group
- Cerus Endovascular Inc.
- Evasc Medical Systems Corp.
- Imperative Care Inc.
- Integer Holdings Corp.
- Integra Lifesciences Corp.
- Johnson and Johnson Services Inc.
- Kaneka Corp.
- Lepu Medical Technology Beijing Co. Ltd.
- Medtronic Plc
- MicroPort Scientific Corp.
- Penumbra Inc.
- Perflow Medical Ltd.
- phenox GmbH
- Rapid Medical Ltd.
- SENSOME
- Stryker Corp.
- Terumo Corp.
